https://www.foldax.com https://www.foldax.com/about https://www.foldax.com/news https://www.foldax.com/contact https://www.foldax.com/clinical-references https://www.foldax.com/privacy https://www.foldax.com/terms-of-use https://www.foldax.com/our-technology https://www.foldax.com/clinical-evidence https://www.foldax.com/patients https://www.foldax.com/in/patient-registry https://www.foldax.com/partnerships https://www.foldax.com/in/home https://www.foldax.com/in/our-technology https://www.foldax.com/in/clinical-evidence https://www.foldax.com/in/patients https://www.foldax.com/in/about https://www.foldax.com/in/partnerships https://www.foldax.com/in/news https://www.foldax.com/in/contact https://www.foldax.com/in/clinical-references https://www.foldax.com/in/privacy-policy https://www.foldax.com/in/terms-of-use https://www.foldax.com/resources/a-novel-polymer-tavr-valve-validation-of-design-considerations-from-bench-to-chronic-ovine-model https://www.foldax.com/resources/acc21-presentation-synthetic-leaflets-dont-believe-the-hype-vs-the-future-is-here-by-steven-duff-md https://www.foldax.com/resources/american-heart-association https://www.foldax.com/resources/assessment-of-a-siloxane-poly-urethane-urea-elastomer-designed-for-implantable-heart-valve-leaflets https://www.foldax.com/resources/can-a-robot-make-a-better-heart-valve https://www.foldax.com/resources/challenging-case-first-treatment-with-foldax-tria-tm-surgical-mitral-valve-for-rheumatic-heart-disease-rhd-dr-kaushal https://www.foldax.com/resources/crt-2020-best-innovations-competition-winning-presentation-by-dr-yakubov https://www.foldax.com/resources/crt-700-20-foldax-tria-tavi-a-novel-polymer-transcatheter-aortic-valve-pilot-chronic-ovine-model-study https://www.foldax.com/resources/crt2022-foldax-r-tria-tm-tavi-a-novel-polymer-transcatheter-aortic-valve-pilot-chronic-ovine-model-study https://www.foldax.com/resources/crt23-tria-tavr-validation-of-design-in-chronic-ovine-mode https://www.foldax.com/resources/development-and-preclinical-results-of-a-transcatheter-aortic-valve-implant-with-novel-polymeric-leaflets https://www.foldax.com/resources/development-of-high-strength-siloxane-poly-urethane-urea-elastomers-based-on-linked-macrodiols-for-heart-valve-application https://www.foldax.com/resources/eacts-2024-an-innovative-robotically-manufactured-polymer-valve-establishes-promising-early-clinical-results https://www.foldax.com/resources/eacts-2025-sustained-performance-one-year-outcomes-of-the-tria-mitral-valve https://www.foldax.com/resources/first-tria-tm-heart-valve-implant-at-beaumont-hospital-the-patients-journey https://www.foldax.com/resources/foldax-addressing-the-need-for-better-mitral-valve-replacement https://www.foldax.com/resources/foldax-lifepolymer-and-a-novel-polymeric-heart-valve-pathway-to-clinical-evaluation https://www.foldax.com/resources/foldaxs-lifepolymer-tm-development-partner-has-deep-expertise-in-polymer-development https://www.foldax.com/resources/from-biologic-limits-to-polymeric-possibilities-surgical-and-transcatheter-valves https://www.foldax.com/resources/hard-segment-composition-morphology-tensile-properties-and-biostability-of-linked-macrodiol-based-siloxane-poly-urethane-urea https://www.foldax.com/resources/heart-valve-surgery https://www.foldax.com/resources/heart-valve-voice-us https://www.foldax.com/resources/in-vitro-oxidative-stability-of-high-strength-siloxane-poly-urethane-urea-elastomers-based-on-linked-macrodiol https://www.foldax.com/resources/manufacturing-and-commercializing-polymer-heart-valves https://www.foldax.com/resources/medtech-strategist-article-foldax-advances-the-next-big-thing-in-heart-valves-robotic-manufacturing https://www.foldax.com/resources/morphology-and-surface-properties-of-biopolymer-developed-for-heart-valve-application https://www.foldax.com/resources/ny-valves-2024-innovation-with-a-novel-polymer-heart-valve-tria-tm-portfolio https://www.foldax.com/resources/ny-valves-2025-one-year-results-of-a-clinical-study-using-a-novel-polymeric-valve-for-surgical-mitral-valve-replacement https://www.foldax.com/resources/one-year-results-from-a-multi-center-trial-of-a-polymer-surgical-mitral-valve-insights-into-new-technology https://www.foldax.com/resources/preliminary-evaluation-of-a-novel-polymeric-valve-following-surgical-implantation-for-symptomatic-aortic-valve-disease https://www.foldax.com/resources/reinventing-the-artificial-heart-valve https://www.foldax.com/resources/review-article-polymer-prosthetic-heart-valves-a-review-of-current-technologies-and-future-directions https://www.foldax.com/resources/strain-energy-minimization-technique-to-design-a-surgical-heart-valve-using-a-novel-polymer https://www.foldax.com/resources/surgical-mitral-valve-replacement-with-a-novel-polymeric-valve-30-day-results-from-an-indian-clinical-study-of-the-foldax-r-tria-tm-valve https://www.foldax.com/resources/tct-2003-foldax-r-presentation-robotically-developed-polymeric-based-leaflet-technology-clinical-program-update https://www.foldax.com/resources/tct-2019-foldax-presentation-during-the-innovation-session https://www.foldax.com/resources/the-christ-hospital-becomes-third-in-the-world-to-implant-revolutionary-next-generation-heart-valve https://www.foldax.com/resources/tria-tm-valve-development-assisted-by-caltech-researchers https://www.foldax.com/resources/tvt21-biopolymer-valves-an-alternative-to-tissue-based-valves https://www.foldax.com/resources/tvt22-tria-tavr-chronic-animal-study-positive-results-presented-by-dr-steve-yakubov https://www.foldax.com/news/best-innovations-competition-winners-at-cardiovascular-research-technology-crt-2020-by-crtonline-org https://www.foldax.com/news/first-clinical-study-on-tria-biopolymer-heart-valve-shows-excellent-one-year-performance https://www.foldax.com/news/first-patients-outside-of-u-s-treated-with-tria-biopolymer-surgical-aortic-heart-valve-in-india-clinical-trial https://www.foldax.com/news/first-patients-outside-of-u-s-treated-with-tria-tm-polymer-surgical-mitral-heart-valve https://www.foldax.com/news/foldax-announces-addition-of-scott-huennekens-to-its-board-of-directors https://www.foldax.com/news/foldax-announces-fda-approval-to-begin-an-early-feasibility-study-of-the-tria-tm-heart-valve https://www.foldax.com/news/foldax-announces-first-worldwide-implant-of-the-tria-tm-heart-valve https://www.foldax.com/news/foldax-announces-launch-of-tria-tm-mitral-valve-in-india https://www.foldax.com/news/foldax-announces-medical-device-veteran-greg-casciaro-as-new-ceo https://www.foldax.com/news/foldax-announces-positive-one-year-data-on-tria-tm-mitral-valve https://www.foldax.com/news/foldax-announces-successful-first-human-use-of-tria-biopolymer-mitral-heart-valve https://www.foldax.com/news/foldax-biopolymer-shown-to-possess-ideal-properties-for-heart-valve-in-new-published-paper https://www.foldax.com/news/foldax-completes-enrollment-in-early-feasibility-study-for-tria-biopolymer-surgical-aortic-heart-valve https://www.foldax.com/news/foldax-completes-enrollment-in-tria-tm-lifepolymer-early-feasibility-study https://www.foldax.com/news/foldax-named-a-finalist-in-the-fierce-innovation-awards-life-sciences-edition-2020 https://www.foldax.com/news/foldax-named-among-fierce-medtechs-fierce-15-companies-of-2020 https://www.foldax.com/news/foldax-named-cardiovascular-device-company-of-the-year-by-medtech-outlook https://www.foldax.com/news/foldax-presents-positive-animal-study-data-at-2022-crt-meeting https://www.foldax.com/news/foldax-r-announces-completion-of-enrollment-in-india-clinical-trial-evaluating-tria-tm-polymer-surgical-mitral-heart-valve https://www.foldax.com/news/foldax-r-reports-positive-clinical-results-for-tria-mitral-surgical-heart-valve-using-novel-lifepolymer-material https://www.foldax.com/news/foldax-r-signs-manufacturing-agreement-with-dolphin-life-science-india-llp https://www.foldax.com/news/foldax-receives-approval-for-clinical-trial-of-tria-biopolymer-surgical-aortic-heart-valve-in-india https://www.foldax.com/news/foldax-receives-fda-approval-to-expand-clinical-study-of-novel-biopolymer-aortic-heart-valve https://www.foldax.com/news/foldax-receives-fda-ide-approval-for-biopolymeric-mitral-heart-valve-clinical-study https://www.foldax.com/news/foldax-receives-full-ownership-rights-to-proprietary-polymer-patent-portfolio https://www.foldax.com/news/foldax-secures-approval-for-tria-mitral-heart-valve-in-india https://www.foldax.com/news/foldax-strengthens-scientific-and-medical-advisory-boards https://www.foldax.com/news/foldax-tria-tm-lifepolymer-heart-valve-honored-with-best-innovation-award-at-cardiovascular-research-technology-crt-2020 https://www.foldax.com/news/foldax-wins-2020-medtech-breakthrough-award-for-cardiovascular-technology-innovation https://www.foldax.com/news/heart-valve-innovator-foldax-closes-20-million-financing https://www.foldax.com/news/tria-tm-polymer-surgical-valves-surpass-200-patient-life-years https://www.foldax.com/in/news-in/best-innovations-competition-winners-at-cardiovascular-research-technology-crt-2020-by-crtonline-org https://www.foldax.com/in/news-in/first-clinical-study-on-tria-biopolymer-heart-valve-shows-excellent-one-year-performance https://www.foldax.com/in/news-in/first-patients-outside-of-u-s-treated-with-tria-biopolymer-surgical-aortic-heart-valve-in-india-clinical-trial https://www.foldax.com/in/news-in/first-patients-outside-of-u-s-treated-with-tria-tm-polymer-surgical-mitral-heart-valve https://www.foldax.com/in/news-in/foldax-announces-addition-of-scott-huennekens-to-its-board-of-directors https://www.foldax.com/in/news-in/foldax-announces-fda-approval-to-begin-an-early-feasibility-study-of-the-tria-tm-heart-valve https://www.foldax.com/in/news-in/foldax-announces-first-worldwide-implant-of-the-tria-tm-heart-valve https://www.foldax.com/in/news-in/foldax-announces-medical-device-veteran-greg-casciaro-as-new-ceo https://www.foldax.com/in/news-in/foldax-announces-positive-one-year-data-on-tria-tm-mitral-valve https://www.foldax.com/in/news-in/foldax-announces-successful-first-human-use-of-tria-biopolymer-mitral-heart-valve https://www.foldax.com/in/news-in/foldax-biopolymer-shown-to-possess-ideal-properties-for-heart-valve-in-new-published-paper https://www.foldax.com/in/news-in/foldax-completes-enrollment-in-early-feasibility-study-for-tria-biopolymer-surgical-aortic-heart-valve https://www.foldax.com/in/news-in/foldax-completes-enrollment-in-tria-tm-lifepolymer-early-feasibility-study https://www.foldax.com/in/news-in/foldax-named-a-finalist-in-the-fierce-innovation-awards-life-sciences-edition-2020 https://www.foldax.com/in/news-in/foldax-named-among-fierce-medtechs-fierce-15-companies-of-2020 https://www.foldax.com/in/news-in/foldax-named-cardiovascular-device-company-of-the-year-by-medtech-outlook https://www.foldax.com/in/news-in/foldax-presents-positive-animal-study-data-at-2022-crt-meeting https://www.foldax.com/in/news-in/foldax-r-announces-completion-of-enrollment-in-india-clinical-trial-evaluating-tria-tm-polymer-surgical-mitral-heart-valve https://www.foldax.com/in/news-in/foldax-r-announces-launch-of-tria-tm-mitral-valve-in-india https://www.foldax.com/in/news-in/foldax-r-reports-positive-clinical-results-for-tria-mitral-surgical-heart-valve-using-novel-lifepolymer-material https://www.foldax.com/in/news-in/foldax-r-signs-manufacturing-agreement-with-dolphin-life-science-india-llp https://www.foldax.com/in/news-in/foldax-receives-approval-for-clinical-trial-of-tria-biopolymer-surgical-aortic-heart-valve-in-india https://www.foldax.com/in/news-in/foldax-receives-fda-approval-to-expand-clinical-study-of-novel-biopolymer-aortic-heart-valve https://www.foldax.com/in/news-in/foldax-receives-fda-ide-approval-for-biopolymeric-mitral-heart-valve-clinical-study https://www.foldax.com/in/news-in/foldax-receives-full-ownership-rights-to-proprietary-polymer-patent-portfolio https://www.foldax.com/in/news-in/foldax-secures-approval-for-tria-mitral-heart-valve-in-india https://www.foldax.com/in/news-in/foldax-strengthens-scientific-and-medical-advisory-boards https://www.foldax.com/in/news-in/foldax-tria-tm-lifepolymer-heart-valve-honored-with-best-innovation-award-at-cardiovascular-research-technology-crt-2020 https://www.foldax.com/in/news-in/foldax-wins-2020-medtech-breakthrough-award-for-cardiovascular-technology-innovation https://www.foldax.com/in/news-in/heart-valve-innovator-foldax-closes-20-million-financing https://www.foldax.com/in/news-in/tria-tm-polymer-surgical-valves-surpass-200-patient-life-years https://www.foldax.com/podcast/a-mitral-milestone-clinical-progress-of-the-tria-mitral-valve-at-one-year https://www.foldax.com/podcast/can-foldaxs-polymer-robots-upend-heart-valve-market-nvidias-niewolny-talks-digital-surgery https://www.foldax.com/podcast/early-feasibility-of-a-novel-polymer-for-cardiovascular-use